Sodium ‐glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan

ConclusionsThe degree of BP reduction after SGLT2 inhibitor treatment influenced renal composite outcomes in Japanese T2DM patients with CKD, confirming the importance of blood pressure management in T2DM patients with CKD, even when they are under SGLT2 inhibitor treatment.

Source: Journal of Diabetes Investigation - December 30, 2020 Category: Endocrinology Authors: Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Kazuyoshi Sato, Masaaki Miyakawa, Kouichi Tamura, Akira Kanamori Tags: ORIGINAL ARTICLE Source Type: research